Rheumatoid neutrophilic dermatitis (RND) is a rare extra-articular skin lesion associated with rheumatoid arthritis (RA). Lesions typically occur symmetrically on the extensor surfaces of the extremities and present with variable clinical features. A 78-year-old female with a 2-month history of skin rash on the right forearm and left lower leg, with no other systemic symptoms, visited the dermatology department of our hospital. She had been diagnosed with seropositive RA approximately 20 years ago. The skin rash was asymmetrically distributed and presented with localized pustules, purpura, and edema. The biopsy specimen showed dermal infiltration by neutrophils, leukocytoclasia without vasculitis, and a neutrophilic dermal abscess. No fungi or bacteria were detected on any of the stains. The patient was diagnosed with RND. Clinical improvement was noted after treatment with dapsone, followed by colchicine and methylprednisolone. In this case report, we described the case of a female patient with atypically presented RND and conducted a literature review.

A 15-year-old girl presented with a blue cystic mass on her right chin since birth. Doppler ultrasonography and magnetic resonance imaging confirmed a venous malformation (VM). She underwent three sessions of superficial sclerotherapy using sodium tetradecyl sulfate without imaging guidance. The lesion improved, but she began experiencing eyelid swelling and scleral show after the first treatment. Four months after the last injection, bilateral exophthalmos was confirmed. Thyroid function tests revealed hyperthyroidism and elevated thyroid stimulating hormone receptor-stimulating antibodies. She was diagnosed with dysthyroid ophthalmopathy and treated with antithyroid drugs. One year later, her chin lesion remained stable and the exophthalmos fully resolved. This case highlights the potential for a rare and unexpected distant complication of sclerotherapy. While sclerotherapy is considered one of the most effective therapeutic methods among various treatments for VM, it is also important to understand its potential complications.

Background: Pruritus is the most common symptom of skin diseases. Although the prevalence of pruritus in patients with psoriasis has been reported to be between 60% and 90%, its importance has historically been underestimated. Recently, the number of reported cases in which psoriasis and atopic dermatitis coexist has increased, shedding light on their associations. Objective: To investigate the factors related to pruritus and compare the clinical, laboratory, and histopathologic findings of patients according to pruritus intensity and psoriasis severity. Methods: This study involved a retrospective chart review of 139 patients diagnosed with plaque psoriasis based on biopsies and laboratory tests. We conducted a comparative analysis of pruritus scores, the Psoriasis Area Severity Index (PASI), clinical characteristics, laboratory tests, and histopathologic findings. Results: PASI and pruritus scores were positively correlated, with itching being more pronounced in women than in men. Patients with severe pruritus showed longer disease duration and higher PASI scores than those with milder pruritus. Patients with more severe psoriasis (PASI≥20) showed elevated total serum immunoglobulin E levels, a higher neutrophil-to-lymphocyte ratio, and increased neutrophils in lesional tissue. There was no significant difference in eosinophil count or eosinophilic infiltration between patients with severe and mild pruritus. Conclusion Pruritus is associated with psoriasis severity. In this study, we demonstrated an association between pruritus in patients with plaque psoriasis and laboratory markers and histopathologic factors.

Background: Although patients with malignant melanoma in situ (MIS) have a high survival rate, a risk of recurrence or upstaging remains. Thus, a comprehensive understanding of its prognosis is essential for optimal patient management. Objective: To investigate the clinical characteristics and survival outcomes of Korean patients with MIS. Methods: We retrospectively analyzed the medical records and photographs of patients with MIS treated at a single tertiary center between 2008 and 2021. Clinical features, including diagnosis, treatment, recurrence, and mortality, were examined. Results: A total of 156 patients with MIS were included, with a mean age of 59.3 years. The most common subtype was acral lentiginous melanoma (80.8%). Delayed diagnosis was associated with subungual MIS (SUMis; p ＜0.05). Among the subtypes other than SUMis, 77.3% met three or more of the ABCD criteria for melanoma.Hutchinson’s sign was observed in 67.3% of cases of SUMis. Ulceration was present in only two cases (1.3%).Recurrence occurred in nine patients (5.8%), with four (2.6%) experiencing relapse after 5 years. Upstaging was observed in two patients (1.3%) due to intralymphatic or regional nodal metastasis occurring at 19 and 10 months post-treatment. The 5-year and 10-year melanoma-specific/overall survival rates were 100.0/96.9% and 100.0/89.0%, respectively. Conclusion Although the survival rates of patients with MIS are high, long-term and close follow-up after treatment is essential because of the possibility of late recurrence and rare instances of intralymphatic or regional nodal metastasis. Additionally, the presence of clinical ulceration is highly suggestive of invasive melanoma.